Jun 5th, 2025
Advancing Signal Management: Aligning with Good Pharmacovigilance Practice Module IX Using AI-Powered Pharmacovigilance
In today’s high-stakes pharmaceutical environment, patient safety is no longer merely a regulatory checkbox—it is the cornerstone of public trust, clinical responsibility, and operational excellence. As medicinal products enter global…
Jun 12th, 2024
Cosmetics Regulation: US FDA MoCRA Enters Final Phase
In this Datafoundry Blog, we bring you a timely update regarding the regulation of cosmetics in the US. The US…
May 23rd, 2024
Automation of Safety Case Intake from Narratives and Documents
Efficiency of case intake is critical to safety vigilance operations. However, the conventional approach of receiving the safety case information…
Apr 24th, 2024
Addressing Challenges in Safety Signal Management
Safety concerns associated with therapeutic intervention(s) and immunizations can be detected, analyzed, and minimized only through early identification and having…
Mar 18th, 2024
AI can revolutionize Multi-vigilance for Enhanced Patient Safety
The healthcare landscape is a dynamic ecosystem, constantly growing with new drugs, cosmetics, nutraceuticals, and […]
Feb 15th, 2024
Use of AI in Pharmacovigilance Automation
In the past few years, the domain of Pharmacovigilance (PV) (incl. Cosmetovigilance and Materiovigilance) […]
Feb 8th, 2024
Five Reasons to Adopt an AI-Powered Literature Surveillance Solution for Pharmacovigilance
In the rapidly evolving landscape of pharmacovigilance (PV), ensuring patient safety and health outcomes is non-negotiable. With the surge in…
Jan 16th, 2024
The need for a Safety Vigilance BPaaS Model
The challenges of Safety Vigilance in Pharma, Cosmetics, Devices, Vaccines and Nutraceuticals are creating a […]
Dec 15th, 2023
Understanding and Harnessing the Exponential Growth of Life Sciences Data
Navigating the Tsunami of Data According to a recent report by Arcadia Approximately 30% of […]